ARTHUR DAVID J. (Chief Executive Officer) purchased 16.9% of their position (43.90K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $8.0K — a significant purchase. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 5/31/2022ACC: 0001615219-22-000087
DirectorOfficer· Chief Executive Officer
Since Jul 2019
+43.90K
Net shares
Net buyer
$8.0K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
43.90K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+3.40K
Price / share
$0.18
Trade value
$612.00
% of position
1.3%
5/26/2022
259.67K→263.07K
Common Stock
Direct
Shares
+18.60K
Price / share
$0.18
Trade value
$3.39K
% of position
7.1%
5/26/2022
263.07K→281.67K
Common Stock
Indirect
Shares
+708.00
Price / share
$0.18
Trade value
$127.44
% of position
0.3%
5/26/2022
281.67K→282.38K
Common Stock
Indirect
Shares
+10.39K
Price / share
$0.18
Trade value
$1.87K
% of position
3.7%
5/26/2022
282.38K→292.77K
Common Stock
Indirect
Shares
+10.80K
Price / share
$0.18
Trade value
$1.99K
% of position
3.7%
5/26/2022
292.77K→303.57K
Total
Net shares
+43.90K
Net value
$7.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2022 | P · Purchase | +3.40K | $0.18 | $612.00 | 1.3% | 259.67K | 263.07K |
| Common Stock Direct | 5/26/2022 | P · Purchase | +18.60K | $0.18 | $3.39K | 7.1% | 263.07K | 281.67K |
| Common Stock Indirect | 5/26/2022 | P · Purchase | +708.00 | $0.18 | $127.44 | 0.3% | 281.67K | 282.38K |
| Common Stock Indirect | 5/26/2022 | P · Purchase | +10.39K | $0.18 | $1.87K | 3.7% | 282.38K | 292.77K |
| Common Stock Indirect | 5/26/2022 | P · Purchase | +10.80K | $0.18 | $1.99K | 3.7% | 292.77K | 303.57K |
| Total | +43.90K | $7.98K | ||||||
Derivative Transactions0
No derivative transactions reported